{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:07:43Z","timestamp":1783004863033,"version":"3.54.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.mayocp.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T01:07:00Z","timestamp":1657156020000},"page":"1771-1773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative"],"prefix":"10.1016","volume":"97","author":[{"given":"Eli Y.","family":"Adashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5125-2991","authenticated-orcid":false,"given":"Philip A.","family":"Gruppuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2022.07.002_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.mayocp.2022.07.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100180","article-title":"Breakthrough infections after COVID-19 vaccination: insights, perspectives and challenges","volume":"14","author":"Amanatidou","year":"2022","journal-title":"Metabol Open"},{"issue":"7855","key":"10.1016\/j.mayocp.2022.07.002_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mayocp.2022.07.002_bib4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/vaccines9121499","article-title":"Nasal and salivary mucosal humoral immune response elicited by mRNA BNT162b2 COVID-19 vaccine compared to SARS-CoV-2 natural infection","volume":"9","author":"Guerrieri","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.mayocp.2022.07.002_bib5","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1473-3099(20)30274-7","article-title":"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study","volume":"20","author":"Jahnmatz","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.002_bib6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/22221751.2022.2053365","article-title":"A\u00a0nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants","volume":"11","author":"Lam","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.002_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-022-01002-1","article-title":"Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"606","key":"10.1016\/j.mayocp.2022.07.002_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg1143","article-title":"A\u00a0recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters","volume":"13","author":"Wu","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mayocp.2022.07.002_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn6868","article-title":"Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model","author":"Langel","year":"2022","journal-title":"Sci Transl Med"},{"issue":"16","key":"10.1016\/j.mayocp.2022.07.002_bib11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"7830","key":"10.1016\/j.mayocp.2022.07.002_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622003883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:38:27Z","timestamp":1758418707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0025619622003883"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.07.002","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}